Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Okurut

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Fungi (Basel, Switzerland)|January 27, 2018
Monocyte Phenotype and IFN-γ-Inducible Cytokine Responses Are Associated with Cryptococcal Immune Reconstitution Inflammatory SyndromeDavid B Meya, Samuel Okurut, Godfrey Zziwa, et al.
The Journal of Infectious Diseases|August 21, 2025
Cerebrospinal Fluid Mononuclear Cell Phenotype and Activation Predictors of 2-week and 1-year survival among Persons with HIV-Associated Cryptococcal MeningitisMorris K Rutakingirwa, Kenneth Ssebambulidde, Samuel Okurut, et al.
Nature Communications|December 18, 2023
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapyAbigail R Gress, Christine E Ronayne, Joshua M Thiede, et al.
Plos Neglected Tropical Diseases|February 10, 2025
Impact of cerebrospinal fluid leukocyte infiltration and activated neuroimmune mediators on survival with HIV-associated cryptococcal meningitisSamuel Okurut, David R Boulware, Yukari C Manabe, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2024
Impact of Cerebrospinal Fluid Leukocyte Infiltration and Neuroimmmune Mediators on Survival with HIV-Associated Cryptococcal MeningitisSamuel Okurut, David R Boulware, Yukari C Manabe, et al.
Infection and Immunity|December 25, 2019
B Cell Compartmentalization in Blood and Cerebrospinal Fluid of HIV-Infected Ugandans with Cryptococcal MeningitisSamuel Okurut, David B Meya, Freddie Bwanga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2024
Implementation of Single High-dose Liposomal Amphotericin B Based Induction Therapy for Treatment of HIV-associated Cryptococcal Meningitis in Uganda: A Comparative Prospective Cohort StudyJane Gakuru, Enock Kagimu, Biyue Dai, et al.
The Journal of Infectious Diseases|January 13, 2026
CSF Hypo-Inflammation Drives Mortality in HIV-Associated Tuberculous MeningitisAnna L Wilt, David B Meya, Fiona V Cresswell, et al.
The Journal of Infectious Diseases|December 11, 2014
Cellular immune activation in cerebrospinal fluid from ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndromeDavid B Meya, Samuel Okurut, Godfrey Zziwa, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Utility of Cerebrospinal Fluid Protein Levels as a Potential Predictive Biomarker of Disease Severity in HIV-Associated Cryptococcal MeningitisJohn Kasibante, Eesha Irfanullah, Abduljewad Wele, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Fungi (Basel, Switzerland)|January 27, 2018
Monocyte Phenotype and IFN-γ-Inducible Cytokine Responses Are Associated with Cryptococcal Immune Reconstitution Inflammatory SyndromeDavid B Meya, Samuel Okurut, Godfrey Zziwa, et al.
The Journal of Infectious Diseases|August 21, 2025
Cerebrospinal Fluid Mononuclear Cell Phenotype and Activation Predictors of 2-week and 1-year survival among Persons with HIV-Associated Cryptococcal MeningitisMorris K Rutakingirwa, Kenneth Ssebambulidde, Samuel Okurut, et al.
Nature Communications|December 18, 2023
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapyAbigail R Gress, Christine E Ronayne, Joshua M Thiede, et al.
Plos Neglected Tropical Diseases|February 10, 2025
Impact of cerebrospinal fluid leukocyte infiltration and activated neuroimmune mediators on survival with HIV-associated cryptococcal meningitisSamuel Okurut, David R Boulware, Yukari C Manabe, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2024
Impact of Cerebrospinal Fluid Leukocyte Infiltration and Neuroimmmune Mediators on Survival with HIV-Associated Cryptococcal MeningitisSamuel Okurut, David R Boulware, Yukari C Manabe, et al.
Infection and Immunity|December 25, 2019
B Cell Compartmentalization in Blood and Cerebrospinal Fluid of HIV-Infected Ugandans with Cryptococcal MeningitisSamuel Okurut, David B Meya, Freddie Bwanga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2024
Implementation of Single High-dose Liposomal Amphotericin B Based Induction Therapy for Treatment of HIV-associated Cryptococcal Meningitis in Uganda: A Comparative Prospective Cohort StudyJane Gakuru, Enock Kagimu, Biyue Dai, et al.
The Journal of Infectious Diseases|January 13, 2026
CSF Hypo-Inflammation Drives Mortality in HIV-Associated Tuberculous MeningitisAnna L Wilt, David B Meya, Fiona V Cresswell, et al.
The Journal of Infectious Diseases|December 11, 2014
Cellular immune activation in cerebrospinal fluid from ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndromeDavid B Meya, Samuel Okurut, Godfrey Zziwa, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Utility of Cerebrospinal Fluid Protein Levels as a Potential Predictive Biomarker of Disease Severity in HIV-Associated Cryptococcal MeningitisJohn Kasibante, Eesha Irfanullah, Abduljewad Wele, et al.
Pageof 3